Researchers used a specialized brain imaging technique to measure blood flow in the brains of ME/CFS patients and compared it to healthy people. They found that patients with ME/CFS have reduced blood flow in several areas of the limbic system—the part of the brain that helps control emotions, automatic body functions, and memory. The amount of reduced blood flow was also linked to how severe patients' symptoms were.
Why It Matters
This study provides objective neuroimaging evidence that ME/CFS involves measurable changes in brain blood flow, supporting the biological basis of the disease and helping explain cognitive and autonomic symptoms. Identifying specific brain regions affected by hypoperfusion may guide future diagnostic biomarkers and targeted therapeutic interventions.
Observed Findings
Anterior cingulate cortex showed significantly reduced blood flow in ME/CFS patients compared to controls
Putamen and pallidum exhibited hypoperfusion in the patient group
Anterior ventral insular area displayed reduced blood flow in ME/CFS patients
Symptom severity score correlated with reduced blood flow specifically in the anterior cingulate cortex
Hypoperfusion was detected using stringent statistical thresholds (voxel-wise p ≤ 0.001, FWE-corrected p ≤ 0.01)
Inferred Conclusions
Brain blood flow abnormalities in the limbic system may contribute to ME/CFS pathogenesis
Limbic hypoperfusion correlates with symptom severity, suggesting a relationship between regional perfusion deficits and clinical presentation
The anterior cingulate cortex may be a key region of interest for understanding ME/CFS neurobiological mechanisms
Remaining Questions
Is the limbic hypoperfusion a primary cause of ME/CFS or a consequence of the disease process?
How do these blood flow abnormalities relate to specific symptom domains (e.g., cognitive dysfunction vs. autonomic symptoms)?
What This Study Does Not Prove
This study cannot establish whether reduced blood flow causes ME/CFS symptoms or results from the disease process—correlation does not equal causation. The cross-sectional design means we cannot determine whether blood flow abnormalities precede symptom onset or how they change over time. The findings also cannot be generalized beyond the specific patient population studied without replication.